Mindfulness-Based Interventions for the Improvement of Well-Being in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Study Goal
The researchers aimed to meta-analytically review the effects of mindfulness-based interventions (MBIs) on the well-being of people with multiple sclerosis (MS).
Results Summary
MBIs showed moderate to large effects in improving well-being, particularly in reducing stress (Hedges' g = 1.07) and improving depression (g = 0.77) and anxiety (g = 0.63) symptoms, with lasting benefits at follow-up (g = 0.55).
Population
People with multiple sclerosis (MS).
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
mindfulness-based interventions (MBIs) | increase | well-being | people with multiple sclerosis (MS) | Hedges' g = 0.70 | effective | #1 |
mindfulness-based interventions (MBIs) | increase | well-being | people with multiple sclerosis (MS) | g = 0.55 | lasting effects | #2 |
mindfulness-based interventions (MBIs) | decrease | stress | people with multiple sclerosis (MS) | g = 1.07 | highly reduce | #3 |
mindfulness-based interventions (MBIs) | increase | depression symptoms | people with multiple sclerosis (MS) | g = 0.77 | improve | #4 |
mindfulness-based interventions (MBIs) | increase | anxiety symptoms | people with multiple sclerosis (MS) | g = 0.63 | improve | #5 |
OBJECTIVE: The study aims to meta-analytically review studies about the effects of mindfulness-based interventions (MBIs) on well-being of people with multiple sclerosis (MS). METHODS: Seven electronic databases were searched from June 2018 to September 2018. A systematic review and a meta-analysis were conducted. RESULTS: Twenty-one studies were included in qualitative synthesis, and 10 studies were included in meta-analysis. MBIs are effective with an overall moderate effect size (Hedges' g = 0.70) in improving well-being in people with MS, with lasting effects at the follow-up (g = 0.55). In particular, MBIs demonstrated to highly reduce stress (g = 1.07) and to improve depression and anxiety symptoms with a moderate to large effect at postintervention (g = 0.77 and g = 0.63, respectively). CONCLUSIONS: MBIs represent a valid and effective mind-body intervention to improve the well-being of patients with MS. Further studies should investigate which components of MBIs could be more beneficial for patients with progressive MS. PROSPERO REGISTRATION: CRD42018099704.